Objective. To assess the relationship between patients' self-efficacy and the occurrence of adverse events in patients with insulinusing, type-2 diabetes mellitus in an ambulatory setting.
Introduction
Patient safety has become one of the top priorities in patient self-care performance. In a number of research studies on adverse events (AEs) in hospitals, mostly in developed countries have shown that AEs are preventable [1, 2] . However, there were fewer studies in developing countries, some of which estimated high percentage of serious incidents and preventability [3] [4] [5] . It is also worth noting that the primary interest of the adverse-event studies has usually been inpatient settings. The possible explanations might include detectability and manageability, as well as the subsequent impacts of events, such as disability and death. There were only few studies of patient safety that were done in an ambulatory setting dealing with chronically ill patients. Although there were studies of quality of care and service, they put more emphasis on issues like patients' self-management, education and risk factors [6] [7] [8] [9] [10] [11] .
Compared with hospital treatment, patients in an ambulatory setting have larger roles and more contributions to the processes and outcomes of health care [9, [12] [13] [14] [15] [16] . Although healthcare providers, including physicians and nurses, still play important roles in medical management of these patients, ambulatory patients are at risk for AEs due to non-adherence, as well as errors in healthcare processes. No study has clearly indicated any significance between patients' abilities in managing their care and prevention of AEs. We, therefore, aimed to study the occurrence of AEs in an ambulatory care settings and its relationship to patients' selfcare management, or self-efficacy. We chose insulin-using, type-2 diabetic patients as a tracer subjects. Diabetes carried the risk as in who have using insulin increase risk and danger from severe hypoglycemia, with the prevalence of 46% in 2011 [17] .
Methods Study design and samples
A 1-year prospective cohort study was conducted in a diabetic clinic of a university-affiliated tertiary-care hospital in Bangkok between April, 2010 and July, 2011. An initial group of 594 diabetic patients, as shown in Fig. 1 , was recruited for study using a three-step approach. First, using information in their medical records, the clinic's patients were screened at the time of their visits, if they fitted the following inclusion criteria (having type-2 diabetes mellitus, being treated with insulin, age >20 years), and exclusion criteria (having more than five comorbid conditions, being pregnant or lactating, using contraceptive pills, being HIV infected, having psychiatric diseases and refusing participation). Secondly, qualified patients went through random selection by random numbers. Lastly, the selected patients volunteered and gave informed consent. The recruitment process took around 4 months to complete.
All recruited patients completed a pre-test questionnaire (see below) to assess their self-efficacies. Scores were ranked by percentiles. Those with pre-test (Month 0) scores in the first quartile (157 patients) were assigned to the 'low' self-efficacy group, while the 153 patients who scored above the third quartile were assigned to the 'high' self-efficacy group. Both groups were followed up every 3 months for a period of 1 year.
At the baseline (Month 0), the average self-efficacy scores for the 'low-' and 'high-' score groups were 53.1 (SD 5.2) and 67.6 (SD 4.2), respectively. The score differences-total as well as for each problem-solving and daily-living abilitiesbetween the groups remained throughout the 1-year follow-up period, although the scores of the low group showed a slightly improving trend. Patients in both groups attended the same diabetic clinic. Health education and patient support activities were available to all without caregivers in the clinic's knowing the selfefficacy scores.
Instruments
At Month 0, pre-test self-efficacy scores of all patients were collected using validated self-efficacy questionnaires modified from the Diabetes Self-care Scale [18] . The questionnaire was designed to measure a patient's self-efficacy, including knowledge, understanding, skills and behaviors in self-management, in problem-solving and in daily-living skills [19] . It consists of 20 questions organized into 2 dimensions: 10 questions in the problem-solving dimension and the other 10 questions in the daily-living dimension (See Appendix 1). The problem-solving dimension focuses on hypo-hyperglycemia, sickness management, medication and monitoring. The daily-living dimension aims at assessing disease process, nutritional management, physical activity, goal setting, psychosocial adjustment and foot care. All questions can be answered on a five-point scale, ranging from 'strongly disagree = 1' to 'strongly agree = 5'. The questionnaire was validated for content and compatibility with Thai culture, and by a back-translation process Language Institute, Chulalongkorn University. Its reliability level of 0.84 was tested using Cronbach's alpha. The patients' self-efficacies were re-assessed at follow-up visits every 3 months using the same questionnaire.
Information on basic characteristics of patients in both groups was collected, including confounding factors: gender, age, education levels, marital status, income, health insurance eligibility and duration of having known to have diabetes. Information on diabetic treatments and disease control, including body mass index, was also collected as baseline in Month 0 (see Table 1 ). They were subsequently treated as potential confounding factors.
The main outcome of the study, AEs in ambulatory diabetic care, were collected for periods of Months 1-3, 4-6, 7-9 and 10-12, at the follow-up visits using another information sheet. For the purpose of this study, the definition of AEs was adapted from World Health Organization definitions [20] to apply in an ambulatory setting. They were defined as unplanned incidents related to medical management or self-care by a patient, which were directly associated with diabetic care, and leading to patient harm. Details of types of the AEs, including patient harms, were shown in Table 3 . In case, such incident could be managed by the patient and resulted in no harm, it was defined as a near miss. Moreover, possible precipitating factors of an incident were gathered based on history taking on the patient.
Data collection
After the patients' informed consents was obtained (Month 0), patients in both groups were followed every 3 months for a year at the end of Months 3, 6, 9 and 12. In addition to the Month 0 pre-test of self-efficacy, the self-efficacy questionnaire interviews were repeated at the Month 3, 6 and 9 visits. Using a pre-designed information sheet, data on any AEs and near misses of the Months 1-3, 4-6, 7-9 and 10-12 periods were collected at the Months 3, 6, 9 and 12 visits, respectively. At each visit, the patient was interviewed by a nurse from a different clinic and by staff who were trained in research objectives, methods, patient rights, the self-efficacy questionnaire and the application of the information sheet on AEs.
At the Months 3, 6, 9 and 12 follow-up visits, additional information on body mass index, hemoglobin A1C levels, selfmonitoring of blood glucoses (SMBG), income and dose of insulin were also gathered.
Each recruited patient was interviewed by a trained project staff to measure self-efficacy in self-care management. The selfefficacy scores, collected at the beginning of the period from this first assessment, were also used as the baseline (Month 0) for future comparison. All 310 patients in both groups were followed for a year, as shown in Fig. 1 . Furthermore, all the patients were asked to report any AEs, along with related details, occurring in the past 3 months, as a period prevalence using the 'Occurrence Report Questionnaire'. Harm was measured by the need for an unplanned visit to a clinic, hospital or emergency care for treatment, an unplanned admission to a hospital, a temporary or permanent disability or the patient's death. The patients who reported having AEs were asked to explain the nature of the incident, any resulting harm. They were also asked to describe what they were doing when the incidents occurred, how they responded and managed themselves, any assistance they received and related diagnoses and treatment. For near misses, the patients were asked to report information on symptoms, such as excessive sweating or signs of palpitation and how they managed the incidents, including whether they drank sugar containing liquid after the event. Missing visits, that could be suggestive of loss to follow-up or patient death, were verified in the hospital's computerized database which linked with the government's civil registration database.
Data analysis
Basic characteristics of patients in the 'low self-efficacy' and 'high self-efficacy' groups were analyzed by descriptive statistics, including frequency percentages, means and standard deviations. Some of the key characteristics were tested for comparability between groups, using chi-squared tests. The self-efficacy scores were calculated by simple summation of their responses to questions in the questionnaire for each dimension-namely the 'problem-solving' scores and 'dailyliving' scores-these were then summed into the total scores. The scores at Month 0 and subsequent visits at the end of Months 3, 6 and 9 were considered to be the score of the beginnings of Month 1-3, 4-6, 7-9 and 10-12 follow-up periods, respectively.
Frequencies of AEs and near misses were summarized by the patient groups and by the 3-month follow-up periods. The four 3-month figures in each group were combined into annual figures. They were, then, divided by the number of subjects in each group and multiplied by 12/100 in order to calculate 1-year incidence rates (events per 100 person-months). Relative risks (RRs), along with 95% confidence intervals, for the differences in the occurrences of AEs and of AEs plus near misses and between the groups for each follow-up interval were calculated to assess the magnitude of overall risks due to differing levels of self-efficacy. The statistical significance of the difference between the 1-year incident rates was estimated by chi-squared tests.
In addition, any bivariate relationship between potential confounders and occurrences of AEs were explored by chi-squared tests, or Fisher's exact tests, as appropriate. While maintaining practical interpretation, subgroups of some of the potential confounders, such as income statuses, were combined before entering multiple negative binomial regression analyses to avoid a zero-cell phenomenon. The risk of AEs between the two groups with different levels of self-efficacy (SE group) was, then estimated and controlled for the significant confounders from the bivariate tests by a Poisson regression. The model structure in its final form is as follows:
where LIis the use of long-acting insulin; Age the patient age group; ID the insulin dosage group; SMBG the use of selfmonitoring of blood glucoses and Status the marital status.
With four repeated measurements for each subject, the generalized estimating equation (GEEs) was applied for model estimation. The exchangeable correlation matrix for working covariance structures was assumed, that is, within a data clusterwithin a subject-any two observations were assumed equally correlated, and there was no correlation between observations from different clusters. 
Results
Over the follow-up period of 1 year, there were 47 reports of AEs and 367 near misses from both groups. In the low self-efficacy group, some 39 AEs were reported, equal to 2.12 events per 100 person-months (see Table 2 ). With an exception of one case who experienced two AEs in Months 7-9 and Months 10-12, the rest of the group experienced only one event over a year. The distribution of the incidents was quite level as there were 11, 8, 11, 9 events in Months 0-3, 4-6, 7-9 and 10-12, respectively. Almost 80% of the events happened at home, while only 18% occurred in public places. Nearly 43% were after dark, particularly between the hours of 10.00 p.m. and 6.00 a.m. The events first presented with dizziness (14.6%), fainting (12.7%) and syncope (7.0%). After emergency room or hospital visits, the most common diagnosis was hypoglycemia (84.6%), followed by hyperglycemia (7.7%). Others included diabetic ketoacidosis and severe hypoglycemia. Some 16 cases were admitted (41.0%). There was no permanent disability or death (see Table 3 ). In contrast, there were only eight reported AEs in the high self-efficacy group, equaling 0.44 events per 100 personmonths (see also Table 2 ). The events were found in all of the four follow-up intervals. Similar to the former group, a majority of the events occurred at home (5 out of 8), but only two of them happened at night. All of the events were diagnosed as hypoglycemia, among which three incidents resulted in hospital admissions. No permanent disability or death was reported (see also Table 3 ). In addition, the patient interviews indicated precipitating factors of the events included changing time zones, not taking medications on-time, increasing dosage, stopping and reducing dosage, eating smaller meals than usual and not having food after injection. As shown in Table 3 , having other concurrent acute illnesses and incidents after exercise were factors only appearing among the low self-efficacy group.
The incidence of AEs plus near misses was also higher in the low self-efficacy group in comparison with the high self-efficacy group, with the rates of 14.11 events per 100 person-months versus 8.10 events per 100 person-months, respectively. On a quarterly basis, the RRs of AEs of the low self-efficacy group versus the high self-efficacy group indicate higher risks among the patients with lower self-efficacy in all quarters, with the first 3 months being the period of the highest risk, the RRs ranged from 3.6 to 10.7. The quarterly RRs of AEs plus near misses ranged from 1.4 to 2. 4 . On an annual basis, bivariate analyses using GEE Poisson regressions for the repeated measurements estimated the crude RR of AEs at 4.8 times (95% CI: 2.3-9.9) and showed the crude RR of AEs plus near misses at 1.6 times (95% CI: 1.3-1.8) (see Table 4 ).
Additional analyses revealed that 6 out of 17 control variables -including marital status, self-monitoring of blood glucoses, patients age, the use of long-acting insulin, body mass index and dosage of insulin, had statistically significant relationships with the occurrences of AEs. No significant association was found on the other factors, including education, income, health insurance or duration of disease. Applying backward selection with the six variables, the final regression model indicated a significant effect of self-efficacy and the other four confounders on the occurrence of AEs (see Table 5 ). Based on the multiple regression models, the low self-efficacy group was 4.7 times more likely than the high self-efficacy group to have AEs (95% CI with an adjusted RR: 2.1-10.2). No interaction or effect modification among factors was found.
Discussion
AEs in an ambulatory setting were not rare, particularly in patients with chronic diseases that required long-term medication. Based on this study's findings on insulin-using diabetic Period-by-period unadjusted RR
Statistically significant difference in the overall incidence rates between the low-and high self-efficacy groups.
patients, the incidence rate in patients with poor skills in selfmanagement could be as high as 2.12 events per 100 personmonths (26.1% annually). The number was rather high comparing to studies on incidences of severe hypoglycemia of 1.3% in Germany and 1.0% in Southern Finland [21, 22] ; in fact, our findings in low self-efficacy patients raised serious concern. Setting aside some methodological differences between the studies, the magnitude of the risk gaps may be a result of factors such as socio-economic and patients' lifestyles and education. The latter, along with our own finding of an RR of 4.7 times between the low vs. high self-efficacy groups, makes it obvious that patients' self-efficacy in managing their own health not only affects patient outcomes in terms of disease control [23] [24] [25] [26] [27] , but also patient safety. It indicates the critical need for early intervention to enhance knowledge and skills of diabetic patients, particularly those using insulin injections, in taking care of themselves. Based on our findings, the risk may be even higher for the elderly and those using long-acting insulin.
Our study identified possible precipitating factors in the AEs group consistent with what previous studies have shown, including challenges in promoting patients' self-efficacy in managing hypoglycemia [24, 28] , management of co-morbidities and sustained hyperglycemia [14] , diet control and insulin adjustment [13, 16, 29] and excessive exercise [13] . The study by Alastair et al. [30] also showed that AEs in diabetic patients usually occurred at home and at night.
Interestingly, our study also found that the RRs of AEs and near misses were always lower than the risks of AEs alone. This may suggest that patients' self-efficacies could enable them to manage any potential AEs more effectively so that potential harm was averted. This seems consistent with important components of self-efficacy that includes self-management in problem-solving, as measured in our questionnaire. Interviews with this group of patients indicated that they might seek out information on self-care from the internet and social media. They were also eager to attend more educational activities, such as diabetes camps. Our findings, thus, highlight the need for effective empowerment processes offered to patients and families. Diabetic patients should be prepared with knowledge, skills and supports of how to prevent errors in managing their own care. This includes medication taking, diet management, exercises and weight control. This must include how to manage when experiencing early signs of events like hypoglycemia.
Certain limitations of this study should be noted, however. First, it is still possible that incidents might have been underreported. Although we used 3-month follow-ups and a clear definition of AEs as those that required emergency treatment or hospitalization, there was still a threat of patients' recall bias. They could have gone to other places, where we had no access to verify the information. Identification of precipitating factors of AEs was based on history taking from patients. Secondly, it is possible that prior experience of AEs might affect how a patient reported self-efficacy, particularly in follow-up visits. We tried to Note: total number of subjects = 310 (1223 observations).
account for this possibility by using a longitudinal study and monitoring changes in self-efficacy in the Months 3, 6 and 9 visits, in which we found no significant changes. Nonetheless, if prior experience did affect self-efficacy (possibly improve it), this would be beneficial to a patient. Unfortunately, with only one case of repeated incidents over a year, a longer follow-up time might provide more information to address this issue. Lastly, as we put primary focus on internal validity of the results, we should be cautious about generalizability beyond the setting of the urban tertiary-care hospital. This is due to the nature of diabetic patients and their family and community contexts. In addition, due to our prospective cohort design, we recognize that the incidence rates of AEs may not be applied as a reference of patient risk in all hospital ambulatory care facilities or as a representative figure for the hospital or the country.
In conclusion, in order to reduce harmful events and promote safety for chronic-care patients, such as insulin-using, type-2 diabetic patients, healthcare providers should extend their focus beyond the processes within their institutions. As care processes rely heavily on patients' compliance to treatment, behavior and lifestyle, we should put more emphasis on patients' self-efficacy regarding medication management, food, exercise and acute illness in managing their health and disease conditions at home. Patient and family empowerment processes can contribute significantly to patient safety. This would greatly complement our institution-based effort to improve patient safety and quality of care. 
